Chunghwa Chemical

Chunghwa Chemical Synthesis & Biotech (CCSB) is a prominent Taiwan-based contract development and manufacturing organization (CDMO) focused on active pharmaceutical ingredients (APIs). Founded in 1964, the company has evolved from a local manufacturer into a global supplier of high-quality small molecule APIs and intermediates. CCSB specializes in complex chemical synthesis and large-scale fermentation, producing key products such as pravastatin, sirolimus, and mycophenolate mofetil. The company operates cGMP-compliant facilities that are regularly inspected by the US FDA, ensuring adherence to international quality standards. CCSB serves a diverse clientele across the pharmaceutical industry, providing integrated services from process R&D to commercial-scale production.